【レポートの概要（一部）】
Table of Contents
Chapter 1 Research Methodology
1.1 Region Wise Market Calculation
1.1.1 Region Wise Market: Base Estimates
1.1.2 Global Market: CAGR Calculation
1.2 Region based segment share calculation
1.3 Data Analysis
1.4 List of Primary & Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Pharmacogenomics Technology (Theranostics and Companion Diagnostics) Market Variables, Trends& Scope
3.1 Companion Diagnostics: Categorization
3.1.1 Screening and detection
3.1.2 Prognosis
3.1.3 Theranostics
3.1.4 Monitoring
3.1.5 Recurrence
3.2 Market Segmentation & Scope
3.2.1 Market Driver Analysis
3.2.1.1 Rising adoption of companion diagnostics
3.2.1.2 Accelerating demand for targeted cancer treatment & tailored drugs
3.2.1.2.1 Cancer incidence rate,2016
3.2.1.3 Technological advancements pertaining to sequencing
3.2.1.4 Collaborations between diagnostic and pharma entities
3.2.1.4.1 Business models that benefit CDx developers in early partnering deals
3.2.1.5 Growing healthcare expenditure triggering development of effective PM diagnostic & therapeutic procedure for cancer
3.2.2 Market Restraint Analysis
3.2.2.1 Challenges associated with reimbursement
3.2.2.2 Robustness of the financing environment for diagnostic and research tools companies
3.2.2.3 Laboratory developed tests anticipated to reduce adoption of CDx
3.3 Penetration & Growth Prospect Mapping for Therapeutic Area, 2016
3.4 Development of NGS based Companion Diagnostics
3.4.1 Associated operational challenges
3.4.1.1 Assay turnaround time
3.4.1.2 Sample quantity
3.4.1.3 Unavailability of CROs with CLIA NGS capabilities
3.4.2 Technical and analytical challenges for NGS assays in the clinic
3.4.2.1 Design & QC standardization
3.4.2.2 Post analytical challenges
3.4.2.3 Unavailability of CROs with CLIA NGS capabilities
3.4.3 Strategic challenges for drug and diagnostic developers
3.5 Companion Diagnostics Reimbursement Environment
3.5.1 Issues in technology assessment and payer decision making
3.5.2 Potential risks and benefits of pharmacogenomics from the payer perspective
3.6 Companion Diagnostics Regulatory Environment
3.6.1 Companion diagnostics regulatory environment, U.S.
3.6.2 Companion diagnostics regulatory environment, Europe
3.6.3 Companion diagnostics regulatory environment, Asia Pacific
3.7 Companion Diagnostics Regulatory Issues & Recall
3.7.1 Dako FDA warning letter
3.7.2 HercepTest recall
3.7.3 Cobas KRAS test recall
3.7.4 Cobas BRF V600E test recall
3.7.5 Leica Bond HER2 IHC system
3.8 Pharmacogenomics Technology (Theranostics and Companion Diagnostics) – SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.9 Industry Analysis – Porter’s
Chapter 4 Pharmacogenomics Technology: Therapeutic Area Estimates & Trend Analysis
4.1 Pharmacogenomics Technology (Theranostics and Companion Diagnostics) Market: Therapeutic Area Movement Analysis
4.2 Oncology
4.2.1 Global oncology market, 2014 – 2025 (USD Million)
4.2.2 Lung cancer
4.2.2.1 Global lung cancer market, 2014 – 2025 (USD Million)
4.2.3 Breast cancer
4.2.3.1 Global breast cancer market, 2014 – 2025 (USD Million)
4.2.4 Colorectal cancer
4.2.4.1 Global colorectal cancer market, 2014 – 2025 (USD Million)
4.2.5 Cervical cancer
4.2.5.1 Global cervical cancer market, 2014 – 2025 (USD Million)
4.2.6 Other cancers
4.2.6.1 Global other cancers market, 2014 – 2025 (USD Million)
4.3 Neurology
4.3.1 Global neurology market, 2014 – 2025 (USD Million)
4.4 Cardiovascular Diseases
4.4.1 Global cardiovascular diseases market, 2014 – 2025 (USD Million)
4.5 Immunological Disorders
4.5.1 Global immunological disorders market, 2014 – 2025 (USD Million)
4.6 Other Disorders
4.6.1 Global other disorders market, 2014 – 2025 (USD Million)
Chapter 5 Pharmacogenomics Technology: Technology Estimates & Trend Analysis
5.1 Pharmacogenomics Technology (Theranostics and Companion Diagnostics) Market: Technology Movement Analysis
5.2 Polymerase Chain Reaction(PCR)
5.2.1 Global polymerase chain reaction market, 2014 – 2025 (USD Million)
5.3 In-situ Hybridization
5.3.1 Global in-situ hybridization market, 2014 – 2025 (USD Million)
5.4 Immunohistochemistry
5.4.1 Global immunohistochemistry market, 2014 – 2025 (USD Million)
5.5 Sequencing
5.5.1 Global sequencing market, 2014 – 2025 (USD Million)
5.6 Other Technologies
5.6.1 Global other technologies market, 2014 – 2025 (USD Million)
Chapter 6 Pharmacogenomics Technology: Regional Estimates & Trend Analysis, by Therapeutic Area & Application
6.1 Pharmacogenomics Technology (Theranostics and Companion Diagnostics) Market Share by Region, 2016 & 2025
6.2 North America
6.2.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.2.2 Market, by technology, 2014 – 2025 (USD Million)
6.2.3 U.S.
6.2.3.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.2.3.2 Market, by technology, 2014 – 2025 (USD Million)
6.2.4 Canada
6.2.4.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.2.4.2 Market, by technology 2014 – 2025 (USD Million)
6.3 Europe
6.3.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.3.2 Market, by technology, 2014 – 2025 (USD Million)
6.3.3 Germany
6.3.3.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.3.3.2 Market, by technology, 2014 – 2025 (USD Million)
6.3.4 UK
6.3.4.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.3.4.2 Market, by technology, 2014 – 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.4.2 Market, by technology, 2014 – 2025 (USD Million)
6.4.3 Japan
6.4.3.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.4.3.2 Market, by technology, 2014 – 2025 (USD Million)
6.4.4 China
6.4.4.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.4.4.2 Market, by technology, 2014 – 2025 (USD Million)
6.5 Latin America
6.5.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.5.2 Market, by technology, 2014 – 2025 (USD Million)
6.5.3 Brazil
6.5.3.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.5.3.2 Market, by technology, 2014 – 2025 (USD Million)
6.6 MEA
6.6.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.6.2 Market, by technology, 2014 – 2025 (USD Million)
6.6.3 South Africa
6.6.3.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.6.3.2 Market, by technology, 2014 – 2025 (USD Million)
Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Market participation categorization
7.3 Company Profiles
7.3.1 Illumina Inc.
7.3.1.1 Company Overview
7.3.1.2 Financial Performance
7.3.1.3 Product Benchmarking
7.3.1.4 Strategic Initiatives
7.3.2 F Hoffman La Roche
7.3.2.1 Company Overview
7.3.2.2 Financial Performance
7.3.2.3 Product Benchmarking
7.3.2.4 Strategic Initiatives
7.3.3 Qiagen NV
7.3.3.1 Company Overview
7.3.3.2 Financial Performance
7.3.3.3 Product Benchmarking
7.3.3.4 Strategic Initiatives
7.3.4 Myriad Genetics Inc.
7.3.4.1 Company Overview
7.3.4.2 Financial Performance
7.3.4.3 Product Benchmarking
7.3.4.4 Strategic Initiatives
7.3.5 Agilent Technologies
7.3.5.1 Company Overview
7.3.5.2 Financial Performance
7.3.5.3 Product Benchmarking
7.3.5.4 Strategic Initiatives
7.3.6 Foundation Medicine, Inc
7.3.6.1 Company Overview
7.3.6.2 Financial Performance
7.3.6.3 Product Benchmarking
7.3.6.4 Strategic Initiatives
7.3.7 Leica Biosystems Nussloch GmBH
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product Benchmarking
7.3.7.4 Strategic Initiatives
7.3.8 Merck & Co Inc
7.3.8.1 Company Overview
7.3.8.2 Financial Performance
7.3.8.3 Product Benchmarking
7.3.8.4 Strategic Initiatives
7.3.9 Oxford Cancer Biomarkers Ltd.
7.3.9.1 Company Overview
7.3.9.2 Financial Performance
7.3.9.3 Product Benchmarking
7.3.9.4 Strategic Initiatives
7.3.10 Astra Zeneca
7.3.10.1 Company Overview
7.3.10.2 Financial Performance
7.3.10.3 Product Benchmarking
7.3.10.4 Strategic Initiatives
7.3.11 Thermo Fisher Scientific, Inc.
7.3.11.1 Company Overview
7.3.11.2 Financial Performance
7.3.11.3 Product Benchmarking
7.3.11.4 Strategic Initiatives
7.3.12 Beckman Coulter Inc.
7.3.12.1 Company Overview
7.3.12.2 Financial Performance
7.3.12.3 Product Benchmarking
7.3.12.4 Strategic Initiatives
7.3.13 Abbott Laboratories
7.3.13.1 Company Overview
7.3.13.2 Financial Performance
7.3.13.3 Product Benchmarking
7.3.13.4 Strategic Initiatives
7.3.14 Pfizer
7.3.14.1 Company Overview
7.3.14.2 Financial Performance
7.3.14.3 Product Benchmarking
7.3.14.4 Strategic Initiatives
7.3.15 Focus Diagnostics
7.3.15.1 Company Overview
7.3.15.2 Financial Performance
7.3.15.3 Product Benchmarking
7.3.15.4 Strategic Initiatives
7.3.16 AmeriPath Inc
7.3.16.1 Company Overview
7.3.16.2 Financial Performance
7.3.16.3 Product Benchmarking
7.3.16.4 Strategic Initiatives
7.3.17 Bristol Myers Squibb
7.3.17.1 Company Overview
7.3.17.2 Financial Performance
7.3.17.3 Product Benchmarking
7.3.17.4 Strategic Initiatives
7.3.18 Novartis Ag
7.3.18.1 Company Overview
7.3.18.2 Financial Performance
7.3.18.3 Product Benchmarking
7.3.18.4 Strategic Initiatives
【レポート販売概要】
■ タイトル：ファーマコゲノミクス技術/セラノスティクス/コンパニオン診断（CDx）の世界市場分析■ 英文：Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Analysis By Therapeutic Area (Oncology Neurological, Cardiovascular, Immunology Disorders), By Technology, And Segment Forecasts, 2014 - 2025
■ 発行日：2017年6月9日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW70714019
■ 調査対象地域：グローバル
- 透明導電体としてのメタルメッシュの市場機会分析Metal mesh transparent conductors have come into their own in the past year, emerging as a serious alternative to widely used indium tin oxide (ITO), principally in the touch screen sensor space but also beyond that sector, where meshes are already superior in their ability to effectively spread voltage across a large panel. In fact they have been around for a long time in areas such as solar PV a …
- 世界のインタラクティブホワイトボード市場動向（2012-2016）TechNavio's analysts forecast the Global Interactive Whiteboard market to grow at a CAGR of 6.9 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for dynamic interactive learning. The Global Interactive Whiteboard market has also been witnessing the adoption of interactive whiteboards in e-learning and virtual learning environment …
- 耐衝撃改質剤の世界市場予測（～2021）The global impact modifiers market is projected to reach USD 13.13 Billion by 2021, at a CAGR of 5.0% from 2016 to 2021. The growth of the impact modifiers market is primarily triggered by the huge demand for plastic products from the packaging, construction, automotive, and consumer goods industries. Also, factors such as increasing applicability of impact modifiers across varied end-use industri …
- 刈払機の世界市場2015-2019About brush cutter Garden equipment like brush cutters and power lawn mowers are used to maintain a healthy lawn and garden. Proper mowing, cutting, irrigating, and fertilizing result in a healthy, dense, and high-quality lawn. Innovations in technology like battery-powered brush cutters and lightweight gardening equipment have contributed to people getting more interested in gardening. Vendors ar …
- 教育機関向けERPソリューションの世界市場The education ERP market continues to evolve and exhibits expansive growth in the years to come. ERP in education is not a new concept; ERPs were in full-fledged use in major corporations to ease the management process. The development of technology and widespread demand of computing concepts is currently driving the market for ERP in the education industry. This market is expected to grow substan …
- Range Resources Corporation：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Range Resources Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Range Resources Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an esse …
- 世界のリップケア用品市場動向（2012-2016）TechNavio's analysts forecast the Global Lip Care Products market to grow at a CAGR of 4.58 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing demand for natural and organic lip care products. The Global Lip Care Products market has also been witnessing an increased use of lip care products by men. However, the threat of counterfeit products …
- 配電ユニットの世界市場予測（～2024年）“The power distribution unit market is projected to grow at a CAGR of 7.1% from 2019 to 2024” The power distribution unit market is projected to reach USD 5.2 billion by 2024 from an estimated USD 3.7 billion in 2019, at a CAGR of 7.1% during the forecast period. The rising concerns overpower stability for uninterrupted business operations, rising power distribution unit installations for reducing …
- EMV対応POS端末の世界市場2016-2020About EMV POS Terminals EMV stands for Europay, MasterCard, and Visa. EMV is a standard for payment cards, payment terminals, and for ATMs. The EMV standard was developed to deliver a safe and secure payment transaction between chip-based payment cards and terminals. EMV POS terminals generate a dynamic code for every transaction, makeing it almost impossible for fraudsters to decode and retrieve …
- 世界のギヤードモーター市場2015The Global Geared Motors Industry Report 2015 is a professional and in-depth study on the current state of the Geared Motors industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Geared Motors market analysis is provided for the international markets including development trends, competitive landscape an …
- ハラル食品の世界市場2015-2019Earlier, halal food were prepared for Muslims, but now they are consumed globally by people of all religions and ethnic backgrounds as they are known for their safety, hygiene, and ethical quality, and this factor is driving the global halal food market. With the rise in the demand for halal food products, producers from the non-Muslim countries such as the US, Brazil, and Australia are keen to ta …
- ウエルネス旅行の世界市場2016-2020About Tourism People traveling to domestic or foreign locations and staying for not more than one consecutive year for business, leisure, and other purposes are defined as tourists. Tourism is one of the major sources of income for many countries. It positively affects the economy of both the source and host countries. Technavio’s analysts forecast the global wellness tourism market to grow at a C …
- コイルドチュービングサービスの世界市場：ウェルインターベンション、掘削サービスThis report estimates the coiled tubing market in terms of value in $Million. This has been segmented into component regions and further split into countries. A Coil Tubing (CT) unit usually comprises a set of equipment to perform standard continuous-length tubing operations in the oil & gas fields. Coiled tubes are generally made of low-alloy carbon-steel and range from 0.75 inches to 4 inches in …
- 世界の細胞分離市場：エンドユーザー別、地域別Global Cell Separation Market: About this market Technavio’s cell separation market analysis considers sales from academic institutions and research laboratories, pharmaceutical and biotechnology companies, and hospitals and clinical testing laboratories end-users. Our study also finds the sales of cell separation in Asia, Europe, North America, and ROW. In 2019, the academic institutions and rese …
- 滑石及びパイロフィライトの世界市場動向2014/2015The report presents a thorough study of talc and pyrophyllite, covering both global and regional markets. It aims to give a proper picture of the market, its trends, perspectives and opportunities. Comprehensive data showing talc and pyrophyllite worldwide production, consumption, trade statistics and prices are provided. Each country’s market overview covers the following: talc and pyrophyllite p …
